Zhiyuan Hexin (Beijing) Technology Development Co., Ltd. mainly focuses on biomedical related research and product development, with the goal of building a new ecological medical industry, focusing on technology research and development of cell engineering and tissue engineering and its standardization industry promotion. The company adheres to the core value concept of scientific rigor and thorough research.The companys current main technologies include adult autoimmune cell isolation and long-term deep cryogenic storage technology and clinical-grade neonatal umbilical cord-derived mesenchymal stem cell large-scale culture technology, providing customized cell storage and technical services to the general public.